Capsaicin for acute or chronic non-cancer pain: a review of clinical effectiveness, safety, and cost-effectiveness
Generally, acute pain is defined as lasting less than three months, and chronic pain is defined as pain lasting three months or longer. Acute pain includes pain from sprains, strains, and tendonitis; and muscle aches. Chronic pain includes pain associated with osteoarthritis (OA), neuropathic pain (...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, July 3, 2020
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Generally, acute pain is defined as lasting less than three months, and chronic pain is defined as pain lasting three months or longer. Acute pain includes pain from sprains, strains, and tendonitis; and muscle aches. Chronic pain includes pain associated with osteoarthritis (OA), neuropathic pain (NP), and back pain. There are several treatment options for managing pain; both pharmacological and nonpharmacological options. A variety of pharmacological options such as non-steroidal antiinflammatory drugs (NSAIDs), local anesthetics, tricyclic antidepressants, and capsaicin have been used for pain management. The purpose of this report is to review the clinical effectiveness, safety and cost-effectiveness of capsaicin products for the treatment of acute and chronic non-cancer pain |
|---|---|
| Physical Description: | 1 PDF file (34 pages) illustrations |